Targeted therapy for kidney cancer
Targeted therapy is designed to identify receptors and proteins unique to specific cancer cells. Once attached to the targeted cancer cells, these drugs kill the cells or help other therapies, such as chemotherapy, work better. Among the drugs used in targeted therapy are so-called kinase inhibitors, which target specific enzymes called protein kinases that help regulate cell growth.
Your oncologist may include one or more of the following kinase inhibitor drugs in your treatment plan: sunitinib (Sutent®), sorafenib (Nexavar®), pazopanib (Votrient®), temsirolimus (Torisel®) or everolimus (Afinitor®, Zortress®).
Your doctor may also recommend bevacizumab (Avastin®), a monoclonal antibody and angiogenesis inhibitor designed to prevent cancer cells from developing blood vessels that feed tumors.